Summary
This filing is an Amendment No. 2 to a previous Form 8-K, primarily focused on providing updated pro forma financial information related to Quest Diagnostics' acquisition of Unilab Corporation. The amendment adds unaudited pro forma combined statements of operations for the three months ended March 31, 2003, the six months ended June 30, 2003, and the nine months ended September 30, 2003. This new information allows investors to better assess the financial impact of the Unilab acquisition on Quest Diagnostics' performance on a more recent and sequential basis. Investors should note that this amendment does not alter any previously filed historical or pro forma financial data. Its main purpose is to supplement the previously disclosed pro forma information with more up-to-date quarterly results reflecting the combined entity. This incremental disclosure is crucial for tracking the integration and performance trends of the acquired Unilab business within Quest Diagnostics.
Key Highlights
- 1Quest Diagnostics filed Amendment No. 2 to its Form 8-K, originally dated February 26, 2003.
- 2The amendment's primary purpose is to provide updated unaudited pro forma financial statements.
- 3The new pro forma statements cover the three, six, and nine months ended March 31, June 30, and September 30, 2003, respectively.
- 4These pro forma statements reflect the financial impact of the Unilab Corporation acquisition, completed on February 28, 2003.
- 5No changes are made to previously filed historical or pro forma financial information.
- 6The filing aims to offer investors a more current view of the combined entity's operational performance post-acquisition.